Evidence map›Paper›PMID 30833218›Full record

ArticleMolecular metabolism2019

Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity.

Bernardo Stutz, Carole Nasrallah, Mariana Nigro, Daniel Curry, Zhong-Wu Liu, Xiao-Bing Gao, John D Elsworth, Liat Mintz, Tamas L Horvath

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. In Vivo Study ofPlants (Basel, Switzerland) · 2024
    Article
  4. "Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin.Cellular and molecular life sciences : CMLS · 2022
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

Bernardo StutzProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, USA. Electronic address: bernardo.stutz@yale.edu.
Carole NasrallahProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, USA; Interdepartmental Neuroscience Program, USA.
Mariana NigroDepartment of Obstetrics, Gynecology and Reproductive Sciences, USA.
Daniel CurryDepartment of Psychiatry, USA.
Zhong-Wu LiuProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, USA.
Xiao-Bing GaoProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, USA.
John D ElsworthDepartment of Psychiatry, USA.
Liat MintzDiaLean East Brunswick, NJ, USA.
Tamas L HorvathProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Department of Comparative Medicine, USA; Interdepartmental Neuroscience Program, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, USA; Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Anatomy and Histology, University of Veterinary Medicine, Budapest, 1078, Hungary. Electronic address: tamas.horvath@yale.edu.
Society for Neuroscience · USUniversity Surgical Associates · USSwiss Institute of Comparative Law · CH

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
PET imaging of AD-related markers in non-human primatesR01AG052986 · NIA · YALE UNIVERSITY · PI HORVATH, TAMAS L, LAWRENCE, MATTHEW SWAN · 2017 to 2020
$2.9M
Developmental Factors for Reducing Dopamine Loss in Primate Models of PD & AgingR01AG048918 · NIA · YALE UNIVERSITY · PI ELSWORTH, JOHN D · 2016 to 2020
$2.4M
AgRP neurons promote the effects of calorie restriction on lifespanR01AG052005 · NIA · YALE UNIVERSITY · PI HORVATH, TAMAS L · 2017 to 2021
$2.2M
Feeding Driven by POMC NeuronsR01DK111178 · NIDDK · YALE UNIVERSITY · PI HORVATH, TAMAS L · 2017 to 2020
$1.9M
In vivo and in vitro systems to validate geronic proteins and their mechanisms of actionR56AG052986 · NIA · YALE UNIVERSITY · PI HORVATH, TAMAS L, LAWRENCE, MATTHEW SWAN · 2016 to 2016
$494k
NCATS NIH HHS UL1 TR001863NIA NIH HHS P01 AG051459NIA NIH HHS R01 AG048918NIA NIH HHS R01 AG052005NIA NIH HHS R01 AG052986NIA NIH HHS R56 AG052986NIDDK NIH HHS R01 DK111178
6 · The paper itself

Abstract

objectiveDopamine neurons in the Substantia nigra (SN) play crucial roles in control of voluntary movement. Extensive degeneration of this neuronal population is the cause of Parkinson's disease (PD). Many factors have been linked to SN DA neuronal survival, including neuronal pacemaker activity (responsible for maintaining basal firing and DA tone) and mitochondrial function. Dln-101, a naturally occurring splice variant of the human ghrelin gene, targets the ghrelin receptor (GHSR) present in the SN DA cells. Ghrelin activation of GHSR has been shown to protect SN DA neurons against 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP) treatment. We decided to compare the actions of Dln-101 with ghrelin and identify the mechanisms associated with neuronal survival.

methodsHistologial, biochemical, and behavioral parameters were used to evaluate neuroprotection. Inflammation and redox balance of SN DA cells were evaluated using histologial and real-time PCR analysis. Designer Receptors Exclusively Activated by Designer Drugs (DREADD) technology was used to modulate SN DA neuron electrical activity and associated survival. Mitochondrial dynamics in SN DA cells was evaluated using electron microscopy data.

resultsHere, we report that the human isoform displays an equivalent neuroprotective factor. However, while exogenous administration of mouse ghrelin electrically activates SN DA neurons increasing dopamine output, as well as locomotion, the human isoform significantly suppressed dopamine output, with an associated decrease in animal motor behavior. Investigating the mechanisms by which GHSR mediates neuroprotection, we found that dopamine cell-selective control of electrical activity is neither sufficient nor necessary to promote SN DA neuron survival, including that associated with GHSR activation. We found that Dln101 pre-treatment diminished MPTP-induced mitochondrial aberrations in SN DA neurons and that the effect of Dln101 to protect dopamine cells was dependent on mitofusin 2, a protein involved in the process of mitochondrial fusion and tethering of the mitochondria to the endoplasmic reticulum.

conclusionsTaken together, these observations unmasked a complex role of GHSR in dopamine neuronal protection independent on electric activity of these cells and revealed a crucial role for mitochondrial dynamics in some aspects of this process.

Indexed as

Action PotentialsAnimalsDopaminergic NeuronsGhrelinMiceMPTP PoisoningNeuroprotective AgentsPeptide FragmentsReceptors, GhrelinSubstantia NigraGhrelinNeuroprotective AgentsPeptide FragmentsReceptors, GhrelinDopamine neuronGHSRMitochondrial dynamicsMitofusin 2Parkinson's

Identifiers

PMID30833218
PMCPMC6531791
OpenAlexW2915654362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.